← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2006Last known activity
Jul 1, 2017
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03093129Reponsible party - principal investigatorPhase 2Jul 1, 2017
- NCT03093129Study directorPhase 2Jul 1, 2017
- NCT03093129Lead sponsorPhase 2Jul 1, 2017
- NCT01018381Lead sponsorN/AJun 1, 2006
- NCT01018381Overall official - principal investigatorN/AJun 1, 2006
Details
- Last known activity
- Jul 1, 2017